Term
Depolarizing neuromuscular blockers |
|
Definition
- AchE inhibitors
- increase levels of Ach
- directly stimulate the nicotinic receptors on the skeletal muscle endplate, producing depolarization of the endplate |
|
|
Term
|
Definition
- depolarizing neuromuscular blockers
- acts by producing initial contraction followed by a paralysis of the skeletal muscle, which cannot be activated through the Nm receptor
- still used therapeutically
|
|
|
Term
Nondepolarizing neuromuscular blockers |
|
Definition
- D-tubocurare
- antagonize the effects of Ach at the Nm receptor
- the endplate region of skeletal muscle remains polarized
-competitive Nm receptor antagonists
- produce flaccid paralysis
|
|
|
Term
|
Definition
- act directly on the skeletal muscle
to produce relaxation
|
|
|
Term
|
Definition
- act at the motor neuron to interfere with Ach release
- Hemicholinium which inhibits Ach synthesis
- Botulinus toxin
|
|
|
Term
Depolarizing neuromuscular blocker |
|
Definition
- Decamethonium
- not used therapeutically |
|
|
Term
Nondepolarizing neuromuscular blockers |
|
Definition
2 groups:
- the benzylisoquinolinium compounds
- the aminosteroid compounds |
|
|
Term
Benzylisoquinolinium compounds |
|
Definition
- D-tubocurare
- metocurine
- alcuronium
- atracurium
- mivacurium
- placed at the skeletal muscle endplate region (lollipop) |
|
|
Term
|
Definition
- Pancuronium
- Vecuronium
- Rocuronium
- more potent
- they are competitive Nm receptor antagonists
- placed at the skeletal muscle endplate region (lollipop)
|
|
|
Term
Depolarizing neuromuscular blockers |
|
Definition
- produce a persistent (long-acting) depolarization
of the skeletal muscle endplate
- produce transient fasciculations
-they desensitize the skeletal muscle to Ach
(Ach will bind and produce no effect)
|
|
|
Term
|
Definition
- Succinylcholine, it seems to mimic
the effects of Ach
- it stimulates the vagal nerve, and you
get bradycardia as a potential effect
|
|
|
Term
Succinylcholine works in 2 phases: |
|
Definition
Phase 1, the skeletal muscle membrane
depolarizes, you get a transient fasciculation
and flaccid paralysis. (normal agonist effect)
Phase 2, the membrane repolarizes,
but the membrane still will not respond to Ach
(is still desensitized to Ach); the effect
like the inverse agonist.
|
|
|
Term
Adverse CV effects of NM Blockers |
|
Definition
Ganglionic block: Tubocurarine, Metocurine, Alcuronium
Histamine release: Tubocurarine, Metocurine, Alcuronium, Succinylcholine
Vagal stimulation:Succinylcholine
Sympathetic stimulation: Pancuronium |
|
|
Term
|
Definition
- will cause hypotension
- it is blocking sympathetic ganglia
(less vasoconstriction)
- can be produced by Tubocurarine, Metocurine, Alcuronium
|
|
|
Term
Ganglionic blocker on the heart |
|
Definition
- would produce tachycardia because in
the heart, you have dual innervation and
the predominant tone to the
heart is parasympathetic, and it
will be blocked the most.
So you have unopposed sympathetic stimulation.
|
|
|
Term
|
Definition
- dangerous for asthmatics (should be pre-treated with a H-1 receptor antagonist)
-can produce bronchoconstriction, vasodilation, hypotension
|
|
|
Term
|
Definition
- has naked histamine receptors,
- has naked muscarinic receptors
- it has naked beta 2 receptors
|
|
|
Term
|
Definition
- predominant tone is sympathetic |
|
|
Term
|
Definition
|
|
Term
Adverse effects of succinylcholine |
|
Definition
- increased intraoccular pressure- caution in glaucoma!!
- post-operative muscle pain (because of the fasciculations, which cause the contraction of the skeletal muscle)
- hyperkalemia - because of the muscle contractility
- Malignant hyperthermia and succinylcholine apnea
|
|
|
Term
|
Definition
- idiosyncratic response due to the abnormal pseudocholinesterase |
|
|
Term
|
Definition
- compatible with normal cardiac function
- can result in dangerous electrolyte
imbalances, so avoid using succinylcholine
when you have soft tissue trauma
|
|
|
Term
|
Definition
- occurs with halogenated hydrocarbons and succinylcholine, it’s an idiosyncratic response
- excessive calcium release from the sarcoplasmic reticulum that leads to rigidity of the muscle
- also associated with hyperthermia, increased muscle metabolism, resulting metabolic acidosis, and it can result in death. |
|
|
Term
Disposition of neuromuscular blockers |
|
Definition
Hepatic and renal: d-tubocurare, pancuronium, rocuronium, vecuronium, are metabolized by the liver and eliminated through the kidneys.
Plasma cholinesterase is important with succinylcholine!!! |
|
|
Term
|
Definition
Succinylcholine apnea, succinylcholine-induced malignant hyperthermia, along with the halogenated hydrocarbon anaesthetics and cyclopropane – these are agents which have this unique characteristic to it. |
|
|
Term
|
Definition
- metabolized by the pseudocholinesterase
in the plasma
- given to patients with renal or liver problems |
|
|
Term
|
Definition
- metabolized by the pseudocholinesterase and
degraded spontaneously
- given to patients with renal or liver problems |
|
|
Term
Peripherally acting skeletal
muscle relaxant drug uses |
|
Definition
- used as adjuncts to general anaesthesia, as
adjuncts to electroshock therapy |
|
|
Term
|
Definition
Direct-acting agent, increases the binding of calcium to the sarcoplasmic reticulum and
it inhibits the movement of calcium in response to membrane depolarization
It doesn't interfere with voluntary contractions; it
interferes with tiny contractions which depend
on initial release of calcium from
the sarcoplasmic reticulum.
|
|
|
Term
|
Definition
- interferes with brief, phasic contractions. It has negligible effect on sustained tettanic contractions. Contractions associated with spasticities are phasic not sustained.Used in muscle spasticities, and also used to combat malignant hyperthermia |
|
|
Term
Dantrolene adverse effects: |
|
Definition
- transient drowsiness: avoid CNS
depressants / driving;
- hepatotoxicity;
- respiratory depression with impairement of central control of respiration (in people with cervical/ high cervical lesions, or brainstem lesions) |
|
|
Term
|
Definition
Botulinum toxin (Type A) Botox: given locally; works by inhibiting Ach release and causing relaxation of the skeletal muscle responsible for producing the wrinkle
Botulinum toxin (Type B) Myoblock
Also used for: blepharospasms, strabismus, and
cervical dystonia
|
|
|
Term
Adverse effects and precautions of botulinum toxin: |
|
Definition
- aminoglycoside antibiotics and curare-like drugs can potentiate their effects
Curare-like drugs, by blocking the nicotinic
receptors, will potentiate the effects of
drugs which inhibit the release of Ach!!
Xerostomia and dysphagia!!! |
|
|
Term
|
Definition
- potentiates the effect of d-tubocurare |
|
|